NCT06140329View on ClinicalTrials.gov

Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

TerminatedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 10, 2025

Conditions
Autosomal Dominant Optic AtrophyOptic Atrophy, Autosomal DominantOptic Atrophies, HereditaryKjer Optic Atrophy
Trial Locations (7)

1105

Amsterdam University Medical Centers, Amsterdam

2000

Sydney Eye Hospital, Sydney

30625

Medizinische Hochschule Hannover, Hanover

33136

Bascom Palmer Eye Institute, Miami

98104

University of Washington, Seattle

Unknown

Medical University of Graz, Graz

CHU de Rennes, Rennes

Sponsors

Lead Sponsor

PYC Therapeutics
All Listed Sponsors
lead

PYC Therapeutics

INDUSTRY

NCT06140329 - Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation | Biotech Hunter | Biotech Hunter